Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of 20-10-10 mg/kg Pedea (intravenous ibuprofen) for patent ductus arteriosus in infants <28 weeks gestation
2009-011279-56Phase 2Completed
- Sponsor
- Recordati SpA
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ibuprofen in patent ductus arteriosus (PDA), sponsored by Recordati SpA. Primary endpoint: Ductus status at 72 hours. Started Jun 2009; status: completed.
02
Drugs
ibuprofen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on 2009-011279-56.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011279-56.